No drugs are specifically indicated for MASLD, but the FDA has granted accelerated approval to two drugs for non-cirrhotic ...

The Trump administration has directed visa officers to consider obesity and other chronic health conditions when deciding ...

The ongoing saga around federal nutrition aid is yet another moment that highlights how food insecurity can lead to long-term ...

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

The medications aren’t just for diabetes and obesity, but they also aren’t for every ailment.

A new directive by President Donald Trump’s administration could make it more difficult for foreigners to visit or live in ...

Chronic kidney disease now ranks as the ninth leading cause of death globally, affecting 788 million people worldwide, according to major health study.

Pfizer Inc. Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...

The Academy of Nutrition and Dietetics released a new position paper, "The Effectiveness of Medical Nutrition Therapy in Prevention and Treatment of Chronic Disease," published in the Journal of the ...

A Trump administration deal to slash prices on blockbuster weight-loss drugs such as Wegovy and Zepbound is expected to make ...